Products for Research Use Only

(R) -SL18

CAT: 0804-HY-168951-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-168951-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(R) -SL18 is a degrader of ANXA3 and can degrade ANXA3 protein through the ubiquitination pathway. (R) -SL18 inhibits the proliferation, migration, invasion, and colony formation of breast cancer cells and induces apoptosis. (R) -SL18 can be used in the research of triple-negative breast cancer[1].
CAS Number
3023189-40-1
UNSPSC
12352101
Target
Annexin A; Apoptosis
Related Pathways
Apoptosis; Cytoskeleton
Field of Research
Cancer
Smiles
CN1C2=CC=CC=C2C(C3=CC=CC=C3)=N[C@@H](NC(SCC(NC(NC4=CC(Cl)=CC=C4[N+]([O-])=O)=O)=O)=S)C1=O
Molecular Formula
C26H21ClN6O5S2
Molecular Weight
597.07
References & Citations
[1]Liu K, et al. Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer. J Med Chem. 2025 Feb 27.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AnxA3

Alternative Products